BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 14, 2004
View Archived Issues
DNA Vaccine Might Provide Immunity Against Anthrax
Read More
FDA Panel Evaluates SSRIs, Risk Of Suicidal Thoughts
Read More
ID Biomedical's Government Contract Worth Up To C$30M
Read More
Other News To Note
Read More
Chiron Settles With Roche For $78M, Licenses IP To InterMune
Chiron Corp. finalized a settlement agreement with F. Hoffmann-La Roche Ltd. concerning an HIV patent late last week, then announced Monday an agreement to provide InterMune Inc. with its hepatitis C targets. (BioWorld Today)
Read More
Threshold Starts Glufosfamide Phase III In Pancreatic Cancer
Read More